The Australian Living Evidence Collaboration is aware of the preliminary results recently released from the REMAP-CAP trial, with implications for treatment of patients with influenza in critical care.
We are currently developing rapid, robust, evidence-based guidelines, in consultation with relevant organisations, evidence specialists, people with lived experience and clinical experts.
We encourage you to check this page over the coming days and weeks. Follow us on LinkedIn and X to ensure you don’t miss an update, and contact us at [email protected] if you have any questions.
